Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The United States does not have a plan to distribute a vaccine for the coronavirus "in a fair and equitable manner" when one becomes available, Rick Bright, a former health official ousted from his position last month, told the House Energy and Commerce Committee on Thursday.

Why it matters: Bright, who led the Biomedical Advanced Research and Development Authority, cautioned that because one company cannot produce enough vaccine for the country, supply will be limited.

What he's saying: "We need to have a plan in place now to make sure that we can not only fill that vaccine, make it, distribute it, but administer it in a fair and equitable plan," he said.

  • Bright criticized the federal government's chaotic rollout of the coronavirus therapy drug remdesivir, which has been shown to help patients recover from the coronavirus more quickly than patients who receive no treatment.
  • "We have limited doses, and we haven't scaled-up production. And we don't have a plan on how to fairly and equitably distribute [remdesivir]."

The big picture: Bright said a vaccine may become available by "this fall, winter, or maybe even next spring." But he cautioned that the 12 to 18 month timeline that has been touted by some in the Trump administration is an "aggressive schedule."

Go deeper: The race to make vaccines faster

Go deeper

Biden says he would issue nationwide stay-at-home order in face of COVID-flu nightmare

Joe Biden accepts the Democratic Party nomination on Aug. 20. Photo: Olivier Douliery/AFP via Getty Images

Former Vice President Joe Biden told ABC News on Friday that, if elected, he would issue a nationwide stay-at-home order at the recommendation of scientists if coronavirus infections surged in January alongside the flu season.

Why it matters: The country's coronavirus crisis could worsen this winter if hospitals are overwhelmed with patients requiring care from COVID-19 at the same time as the flu. The severity of the influenza season also depends on how many Americans get flu shots.

Aug 21, 2020 - Health

Trump administration blocks FDA from regulating lab-developed tests

Photo: Pier Marco Tacca/Getty Images

The Department of Health and Human Services this week blocked the Food and Drug Administration's ability to regulate lab-developed tests, including for the coronavirus, that have been produced by hundreds of hospitals.

What they're saying: The change prohibits the FDA from overseeing such tests before they're marketed without a detailed rule-making process. HHS said it is taking the action as part of broader Trump administration review of "duplicative actions and unnecessary policies."

Updated 10 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: The good and bad news about antibody therapies — U.S. sets new single-day case record.
  2. Politics: States beg for Warp Speed billions.
  3. World: Taiwan reaches a record 200 days with no local cases.
  4. Education: Surge threatens to shut classrooms down again.
  5. Technology: The pandemic isn't slowing tech.
  6. Travel: CDC replaces COVID-19 cruise ban with less restrictive "conditional sailing order."
  7. Sports: High school football's pandemic struggles.
  8. 🎧Podcast: The vaccine race turns toward nationalism.